1. Legal Nature of Liability

(A) Strict / statutory liability

For many offences under the Drugs and Cosmetics Act:

• Even ignorance is not a defence
• Possession or sale of spurious drugs itself creates liability

(B) Vicarious liability

• Directors, partners, managers can be liable
• Based on “control and responsibility” in business operations

(C) Criminal + civil liability

• Criminal: imprisonment + fine
• Civil: compensation for injury/death
• Regulatory: license cancellation

2. Key Case Laws (Explained in Detail)

Case 1: State of Haryana v. Brij Lal Mittal (1998) (Supreme Court)

Facts:

• Company distributed adulterated and misbranded injections
• Directors/partners challenged their liability

Issue:

Can directors be criminally liable for offences committed by company?

Supreme Court Held:

• Directors/partners can be held liable under Section 34 of the Drugs and Cosmetics Act
• Liability arises when they are in charge of and responsible for conduct of business
• Vicarious liability is clearly recognized under the Act

Principle:

Corporate officers are liable if the offence occurs in the course of business they control.

Importance:

This case is foundational for fixing liability on pharmaceutical companies and distributors in counterfeit drug cases.

Case 2: State of Andhra Pradesh v. Venu Veterinary Division (2002)

Facts:

• Veterinary drug company sold substandard drugs
• Prosecution was challenged arguing lack of manufacturer involvement

Issue:

Can a dealer/distributor be prosecuted without manufacturer being accused?

Supreme Court Held:

• Yes, dealer or distributor alone can be prosecuted
• Liability is independent of manufacturer’s presence in the case
• Each participant in supply chain is separately responsible

Principle:

Distribution of spurious or substandard drugs creates independent criminal liability

Importance:

This case strengthens prosecution against wholesalers and pharmacies, even if they claim they were “misled”.

Case 3: State of Karnataka v. Sri Krishna Pharmaceuticals (1980s line of cases, Supreme Court principle)

Facts:

• Pharmaceutical firm found selling non-standard drugs
• Defence argued lack of intent and reliance on supplier

Issue:

Is intention necessary for conviction under Drugs and Cosmetics Act?

Supreme Court Held:

• Mens rea is not essential
• The Act imposes strict regulatory liability
• Public safety overrides intent considerations

Principle:

Selling substandard or counterfeit medicines is punishable even without guilty intent.

Importance:

This is critical because counterfeit drug cases often involve “we did not know it was fake” defence, which generally fails.

Case 4: Pooja Roy v. Krishnango Bhattacharya (Calcutta High Court)

Facts:

• Wholesale dealer accused of selling spurious medicines with altered expiry dates
• Employee involved in manipulation

Issue:

Can partners/owners be liable for employee misconduct?

High Court Held:

• Partners can be liable if offence occurs in business premises
• Vicarious liability applies under Drugs and Cosmetics Act
• Due diligence defence is limited

Principle:

Owners cannot escape liability by blaming employees if business controls are inadequate.

Importance:

This case is often used in retailer and distributor liability for counterfeit stock found in premises.

Case 5: State of Rajasthan v. Rajasthan Pharmaceutical Laboratory (1981, Supreme Court)

Facts:

• Substandard sodium bromide drug found in company possession
• Manager argued lack of direct involvement

Issue:

Liability of firm and managers for drug quality violations

Supreme Court Held:

• Firm and responsible officers are liable
• Possession and distribution itself triggers offence
• Corporate structure does not protect individuals from prosecution

Principle:

Companies and managers are equally liable for drug safety violations.

Importance:

This case supports prosecution of pharmaceutical companies as legal persons.

Case 6: State of Andhra Pradesh v. Veterinary Division & Anr (Supreme Court principle reaffirmed in later judgments)

Facts:

• Dealer sold substandard veterinary drugs
• Defence claimed product came from licensed manufacturer

Issue:

Does sourcing from licensed manufacturer absolve liability?

Supreme Court Held:

• No immunity for distributors
• Duty of care lies on seller
• Selling spurious/substandard drugs is punishable regardless of source

Principle:

Due diligence is required; blind reliance is not a defence.

Importance:

This is frequently cited in retailer liability cases involving fake medicines in pharmacies.

Case 7: State of Maharashtra v. Damu Gopinath Shinde (Principle applied in pharma evidence cases)

Relevance:

Although not purely pharma-specific, it clarifies evidentiary value.

Held:

• Medical or technical reports alone are not enough
• Must be supported by testimony and cross-examination

Importance:

Used when accused argue:

“Lab report is wrong / not properly proved”

3. Who Can Be Held Liable?

(A) Manufacturer

• Producing counterfeit or substandard drugs
• Highest level of liability

(B) Distributor / wholesaler

• Supplying counterfeit drugs knowingly or negligently
• Often prosecuted under strict liability

(C) Retail pharmacist

• Selling fake medicine to patients
• Liability even without knowledge in many cases

(D) Company directors / partners

• If “in charge of business”
• Vicarious liability applies

(E) Hospital or clinic (in supply chain fraud cases)

• If involved in procurement or distribution

4. Nature of Offences and Punishment

Under the Drugs and Cosmetics Act:

• Spurious drugs (Section 17-B / 27(c))
  • 3 years to life imprisonment (depending on harm caused)
  • Heavy fines
• Adulterated drugs
  • Imprisonment up to life in death cases
• Misbranded drugs
  • Lower but still criminal penalties

5. Key Legal Principles (Summary)

Courts consistently hold:

1. Strict liability applies

No need to prove intention in many cases

2. Entire supply chain is responsible

Manufacturer → Distributor → Retailer

3. Vicarious liability is recognized

Directors/partners can be punished

4. Public health overrides private defence

Courts take a strict approach due to risk to life

5. Due diligence is not absolute defence

Only limited mitigation, not complete immunity

6. Final Conclusion

Liability for counterfeit medication distribution in India is:

• Strict
• Chain-based
• Public-safety oriented
• Severely penal

Courts treat such offences as economic + public health crimes, and repeatedly refuse to accept ignorance or lack of intent as a complete defence.